
Household products giant Reckitt Benckiser has agreed to pay a £10.2m fine after admitting to abusing its market position for the supply of heartburn drug Gaviscon.
The Office of Fair Trading (OFT) had accused the firm in February of restricting competition in the supply of heartburn medicines to the NHS.
The inquiry followed an investigation by the BBC's Newsnight in 2008. Reckitt said it respected the OFT's view and had agreed to settle. But it added that it believed it had acted within the law at the time.
To read the full press report click here.